Heart Care

CaThyro® 5 mg is a specialized antithyroid therapy designed for cats suffering from hyperthyroidism, a common endocrine disorder that leads to overproduction of thyroid hormones and a high metabolic rate. Each uncoated tablet contains Methimazole USP 5 mg, which works by inhibiting thyroid hormone synthesis, helping your cat return to a healthy metabolic state. Formulated for easy oral administration, CaThyro® 5 mg is an ideal first-line treatment to control symptoms such as weight loss, hyperactivity, excessive appetite, and restlessness in hyperthyroid cats. Composition Each uncoated tablet contains: Methimazole USP – 5 mg Excipients – q.s. Indications Treatment of hyperthyroidism in cats Normalizes thyroid hormone levels (T3 & T4) Reduces clinical signs like weight loss, irritability, and increased heart rate Benefits Trusted therapy for feline hyperthyroidism Small, easy-to-administer tablets Improves appetite, energy levels, and overall quality of life Veterinarian-recommended formulation Dosage & Administration Starting Dose: 2.5 mg every 12 hours (half tablet twice daily) After 3 weeks, adjust dosage based on serum total T4 (TT4) levels and clinical response Administer orally on veterinarian’s advice Mechanism of Action Methimazole inhibits thyroid peroxidase, blocking iodide binding to thyroglobulin and thereby reducing T3 & T4 hormone production, restoring normal thyroid function. Warnings & Precautions For oral use in cats only Regular monitoring of thyroid function is recommended Use only under veterinary supervision Keep away from children and other pets Possible Side Effects Mild vomiting, loss of appetite, or lethargy may occur. Discontinue and consult a vet if severe adverse effects appear. Storage Store below 30°C in a cool, dry place. Protect from moisture and sunlight. Brand Manufactured & Marketed by Veko Care Pvt. Ltd., WHO-GMP Certified

Read more less

PETMEDIN™ 10 mg Yum-Tab is a highly palatable, protein-flavored heart medication for dogs with congestive heart failure (CHF) due to dilated cardiomyopathy (DCM) or valvular insufficiency. Manufactured at Veko Care’s WHO-GMP certified facility, it strengthens heart contractions, promotes vasodilation, and improves survival time and quality of life. Moisture-resistant blister strips ensure long-lasting potency. Composition Pimobendan Ph.Eur – 10 mg Excipients – q.s. Indications Management of CHF in dogs Preclinical DCM in large breed dogs to delay CHF onset Dogs with enlarged hearts from mitral valve disease to reduce heart size and prolong life Benefits Enhances cardiac contractility and vasodilation Reduces CHF symptoms such as coughing, lethargy, and difficulty breathing Highly palatable Yum-Tabs for easy administration Moisture-resistant blister packaging for stability Dosage & Administration Dose: 0.25 mg/kg body weight twice daily Administer on an empty stomach, at least 1 hour before feeding Can be combined with diuretics like furosemide if prescribed Follow the veterinarian’s instructions Body Weight (kg) Morning / Evening Dose >20 – 40 1 × 10 mg tablet >40 – 60 1.5 × 10 mg tablets >60 – 80 2 × 10 mg tablets Pharmacology Category: Inodilator (Calcium sensitizer + Phosphodiesterase III inhibitor) Pimobendan increases calcium sensitivity of cardiac myofilaments and inhibits phosphodiesterase III, improving cardiac output and vasodilation. Warnings & Precautions Use only in dogs with cardiac insufficiency Avoid in hypertrophic cardiomyopathy or conditions restricting cardiac output Do not exceed recommended dosage Keep out of reach of children and pets Side Effects Rare side effects include vomiting, diarrhea, lethargy, or anorexia. Effects are usually dose-dependent and reversible by adjusting the dose. Storage Store below 30°C in a dry place, away from food, pets, and children. Brand Manufactured & Marketed by Veko Care Pvt. Ltd., WHO-GMP Certified

Read more less

PETMEDIN™ 5 mg Yum-Tab is a protein-flavored, highly palatable heart medication for dogs with congestive heart failure (CHF) caused by dilated cardiomyopathy (DCM) or valvular insufficiency. Manufactured at Veko Care’s WHO-GMP certified facility, it improves heart contraction, reduces symptoms of CHF, and enhances survival and quality of life. Moisture-resistant blister strips preserve the tablets’ potency. Composition Pimobendan Ph.Eur – 5 mg Excipients – q.s. Indications Management of CHF in dogs Preclinical DCM in large breed dogs to delay CHF onset Dogs with enlarged hearts from mitral valve disease, to reduce heart size and prolong life Benefits Improves cardiac contractility and vasodilation Reduces CHF symptoms such as coughing, lethargy, and breathing difficulties Highly palatable Yum-Tabs make administration stress-free Moisture-resistant packaging ensures stability Dosage & Administration Dose: 0.25 mg/kg body weight twice daily Administer on an empty stomach, at least 1 hour before feeding Can be combined with diuretics like furosemide if prescribed Follow the veterinarian’s instructions Body Weight (kg) Morning / Evening Dose 10 – 20 1 × 5 mg tablet >20 – 40 2 × 5 mg tablets >40 – 60 3 × 5 mg tablets Pharmacology Category: Inodilator (Calcium sensitizer + Phosphodiesterase III inhibitor) Pimobendan increases calcium sensitivity of cardiac myofilaments and inhibits phosphodiesterase III, improving cardiac output and vasodilation. Warnings & Precautions Use only in dogs with cardiac insufficiency Avoid in hypertrophic cardiomyopathy or conditions restricting cardiac output Do not exceed recommended dosage Keep out of reach of children and pets Side Effects Rarely, vomiting, diarrhea, lethargy, or anorexia may occur. Usually dose-dependent and reversible by adjusting dosage. Storage Store below 30°C in a dry place, away from food, pets, and children. Brand Manufactured & Marketed by Veko Care Pvt. Ltd., WHO-GMP Certified

Read more less

PETMEDIN™ 2.5 mg Yum-Tab is a highly palatable, protein-flavored heart medication for dogs with congestive heart failure (CHF) caused by dilated cardiomyopathy (DCM) or valvular insufficiency. Manufactured at Veko Care’s WHO-GMP certified facility, these tablets improve heart function, enhance quality of life, and increase survival time. Moisture-resistant blister strips ensure long-term stability. Composition Pimobendan Ph.Eur – 2.5 mg Excipients – q.s. Indications Treatment of CHF in dogs due to DCM or valvular insufficiency Management of preclinical DCM in large breed dogs Dogs with enlarged hearts from mitral valve disease to slow progression and improve survival Benefits Strengthens heart contraction and promotes vasodilation Reduces CHF symptoms like coughing, lethargy, and breathing difficulty Highly palatable Yum-Tabs for easy administration Moisture-resistant packaging for stability Dosage & Administration Dose: 0.25 mg/kg body weight twice daily Administer on an empty stomach, at least 1 hour before feeding Can be used with diuretics like furosemide if prescribed Always follow your veterinarian’s guidance Body Weight (kg) Morning / Evening Dose 2 – 5 1 × 2.5 mg tablet >5 – 10 2 × 2.5 mg tablets >10 – 20 1 × 5 mg tablet Pharmacology Category: Inodilator (Calcium sensitizer + Phosphodiesterase III inhibitor) Pimobendan increases calcium sensitivity in heart muscles and inhibits phosphodiesterase III, improving cardiac output and vasodilation. Warnings & Precautions Use only in dogs with cardiac insufficiency Avoid in hypertrophic cardiomyopathy or conditions restricting cardiac output Do not exceed the recommended dose Keep out of reach of children Side Effects Rarely, vomiting, diarrhea, lethargy, or anorexia may occur. Usually dose-dependent and reversible by adjusting dosage. Storage Store below 30°C in a dry place, away from food, pets, and children. Brand Manufactured & Marketed by Veko Care Pvt. Ltd., WHO-GMP Certified

Read more less

PETMEDIN™ 1.25 mg Yum-Tab is a highly palatable, protein-flavored heart medication formulated for dogs suffering from congestive heart failure (CHF) caused by dilated cardiomyopathy (DCM) or valvular insufficiency. Manufactured at Veko Care’s WHO-GMP certified facility, these tablets improve heart function, increase survival time, and enhance the quality of life for canine patients. Moisture-resistant blister packaging ensures long-lasting potency. Composition Pimobendan Ph.Eur – 1.25 mg Excipients – q.s. Indications Management of CHF in dogs Preclinical DCM in large breed dogs to delay onset of heart failure Dogs with enlarged hearts from mitral valve disease to reduce heart size and prolong life Benefits Strengthens heart contraction and promotes vasodilation Reduces symptoms like coughing, lethargy, and breathing difficulty Increases survival time and quality of life Highly palatable Yum-Tabs make dosing stress-free Dosage & Administration Dose: 0.25 mg/kg body weight twice daily Administer on an empty stomach, at least 1 hour before feeding Can be combined with diuretics like furosemide if prescribed Always follow your veterinarian’s instructions Body Weight (kg) Morning / Evening Dose 2 – 5 1 × 1.25 mg tablet >5 – 10 2 × 1.25 mg tablets Pharmacology Category: Inodilator (Calcium sensitizer + Phosphodiesterase III inhibitor) Pimobendan increases calcium sensitivity in heart muscles and inhibits phosphodiesterase III, improving cardiac output and vasodilation. Warnings & Precautions Do not exceed the recommended dose For dogs with cardiac insufficiency only Avoid in hypertrophic cardiomyopathy or conditions restricting cardiac output Keep out of reach of children; accidental ingestion may cause tachycardia or hypotension Side Effects Rare side effects include vomiting, diarrhea, lethargy, or anorexia, usually dose-dependent and reversible by adjusting the dose. Storage Store below 30°C in a dry place, away from food, pets, and children. Brand Manufactured & Marketed by Veko Care Pvt. Ltd., WHO-GMP Certified.

Read more less